Data / Drug companies / Megestrol acetate
Megestrol acetate: 17 companies and 24 products in the FDA NDC directory
Megestrol acetate is listed in the FDA National Drug Code Directory by 17 companies, with 24 products in commercial distribution. 24 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are suspension; tablet, and the newest product started marketing on April 27, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 17
- Products
- 24
- Generic (ANDA) products
- 24 (100.0%)
- Application numbers
- 7
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list megestrol acetate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Strides Pharma Science Limited | 3 | tablet; suspension | Generic drugs (ANDA) | April 11, 2022 |
| Bryant Ranch Prepack | 2 | tablet | Generic drugs (ANDA) | April 4, 2022 |
| Major Pharmaceuticals | 2 | tablet; suspension | Generic drugs (ANDA) | December 29, 2025 |
| Pai Holdings, LLC DBA Pai Pharma | 2 | suspension | Generic drugs (ANDA) | October 17, 2025 |
| Precision Dose, Inc. | 2 | suspension | Generic drugs (ANDA) | July 11, 2022 |
| Teva Pharmaceuticals USA, Inc. | 2 | tablet | Generic drugs (ANDA) | October 25, 1996 |
| American Health Packaging | 1 | suspension | Generic drugs (ANDA) | January 5, 2026 |
| Ani Pharmaceuticals, Inc. | 1 | suspension | Generic drugs (ANDA) | July 2, 2024 |
| Atlantic Biologicals Corp. | 1 | suspension | Generic drugs (ANDA) | March 21, 2022 |
| Golden State Medical Supply, Inc. | 1 | suspension | Generic drugs (ANDA) | July 25, 2001 |
| Kesin Pharma Corporation | 1 | suspension | Generic drugs (ANDA) | August 7, 2025 |
| Natco Pharma USA LLC | 1 | suspension | Generic drugs (ANDA) | July 31, 2023 |
| Preferred Pharmaceuticals Inc. | 1 | suspension | Generic drugs (ANDA) | July 12, 2024 |
| Proficient Rx LP | 1 | suspension | Generic drugs (ANDA) | March 1, 2015 |
| Remedyrepack Inc. | 1 | tablet | Generic drugs (ANDA) | April 27, 2026 |
| Upsher-Smith Laboratories, LLC | 1 | suspension | Generic drugs (ANDA) | March 1, 2015 |
| Xttrium Laboratories, Inc. | 1 | suspension | Generic drugs (ANDA) | March 28, 2025 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Suspension | 16 | 66.7% |
| Tablet | 8 | 33.3% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 24 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Progestin | 24 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.